Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate

International Journal of Dermatology

Volumn 53, Issue 3, 2014, Pages

  Kagimoto, Yoshiko ^a   Mizuashi, Masato ^a   Kikuchi, Katsuko ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

CASE REPORT; CHEMICALLY INDUCED; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMAN; HYPERPIGMENTATION; LICHENOID ERUPTION; MIDDLE AGED;

ANTINEOPLASTIC AGENTS; BENZAMIDES; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; HYPERPIGMENTATION; LICHENOID ERUPTIONS; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 84894257790     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12174     Document Type: Letter

References (10)

1. van den Haute V, Antoine JL, Lachapelle JM. Histological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 1989; 179: 10-13.
2. Brouard M, Saurat JH. Cutaneous reactions to STI571. N Engl J Med 2001; 345: 618-619.
3. Roux C, Boisseau-Garsaud AM, Saint-Cyr I, et al. Lichenoid cutaneous reaction to imatinib. Ann Dermatol Venereol 2004; 131: 571-573.
4. Prabhash K, Dovel DC. Lichenoid eruption due to imatinib. Indian J Dermatol Venereol Leprol 2005; 71: 287-288.
5. Dalmau J, Peramiquel L, Puig L, et al. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect. Br J Dermatol 2006; 154: 1199-1219.
6. Raanani P, Goldman JM, Ben-Bassat I. Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol 2002; 20: 869-870.
7. Valeyrie L, Bastuji-Garin S, Revus J, et al. Adverse cutaneous reaction to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003; 48: 201-206.
8. Arora B, Kumar L, Sharma A, et al. Pigmentary changes in chronic myeloid leukemia patients trated with imatinib mesylate. Ann Oncol 2004; 15: 358-359.
9. Mcpherson T, Sherman V, Turner R, et al. Imatinib-associated hyperpigmentation, a side effect that should be recognized. J Eur Acad Dermatol Venereol 2009; 23: 82-83.
10. Mattsson U, Halbritter S, Morner Serikoff E, et al. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three casea. Oral surg Oral Med Pathol Oral Radiol Endod 2011; 111: 12-16.